These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6344348)

  • 1. [Flavellagic acid influence on blood coagulation and hemostasis disturbed by whole body irradiation].
    Pospísil J; Skala E; Zitko M; Dienstbier Z
    Strahlentherapie; 1983 May; 159(5):299-305. PubMed ID: 6344348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Haemostatic action of flavellagic acid in rats subjected to whole-body irradiation (author's transl)].
    Pospísil J; Klir P; Zitko M; Jarý J; Dienstbier Z
    Sb Lek; 1979 Oct; 81(10):302-10. PubMed ID: 515676
    [No Abstract]   [Full Text] [Related]  

  • 3. [Toxicity and effect of flavellagic acid on blood coagulation and haemostasis in healthy rabbits and rabbits exposed to whole-body irradiation (author's transl)].
    Pospísil J; Klír P; Skala E; Vranovská J; Dienstbier Z
    Sb Lek; 1982 Apr; 84(4):115-21. PubMed ID: 7100810
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombus weight as a measure of hypercoagulability induced by drugs.
    MacIomhair M; Lavelle SM
    Thromb Haemost; 1979 Oct; 42(3):1018-21. PubMed ID: 505392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of ellagic acid and heparin on coagulation, fibrinolysis and metastasis in traumatized animals (author's transl)].
    Agostino D; Agostino N
    Sangre (Barc); 1980; 25(6):989-98. PubMed ID: 7221832
    [No Abstract]   [Full Text] [Related]  

  • 6. Some cardiovascular and hematological changes induced in the rat by activation of Hageman factor with ellagic acid.
    Damas J; Remacle-Volon G; Adam A
    Adv Exp Med Biol; 1989; 247A():461-5. PubMed ID: 2603812
    [No Abstract]   [Full Text] [Related]  

  • 7. [Modification to the functional status of the hemostatic system with the use of berberine sulfate].
    Ziablitskiĭ VM; Romanovskaia VN; Umurzakova RZ; Starosel'skaia AN; Mikhal'skaia TIu
    Eksp Klin Farmakol; 1996; 59(1):37-9. PubMed ID: 8704631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of tranexamic acid to influence the ellagic acid-induced hypercoagulable state.
    Girolami A; Cella G; Burul A; Zucchetto M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(2):261-70. PubMed ID: 61921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ellagic acid and hemostasis].
    Girolami A
    Recenti Prog Med; 1969 Oct; 47(4):365-86. PubMed ID: 5317297
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action of purified ellagic acid on coagulation time, compared with crude ellagic acid].
    Girolami A
    Haematologica; 1966; 51(2):96-102. PubMed ID: 4957869
    [No Abstract]   [Full Text] [Related]  

  • 11. [Trial to influence by drugs the post-irradiation disorders of blood coagulation].
    Klír P; Pospísil J; Skala E; Dienstbier Z
    Vnitr Lek; 1971 Oct; 17(10):937-42. PubMed ID: 5110477
    [No Abstract]   [Full Text] [Related]  

  • 12. Ellagic acid-induced acceleration of intravascular clotting and thrombolysis.
    Iatridis SG
    Hemostase; 1966; 6(5):363-72. PubMed ID: 5999895
    [No Abstract]   [Full Text] [Related]  

  • 13. Ellagic acid induced thromboelastographic changes in the normal individual and in several coagulopathies.
    Girolami A; Scarpa R
    Haematol Lat; 1969; 12(2):143-54. PubMed ID: 5309584
    [No Abstract]   [Full Text] [Related]  

  • 14. The evolution of clot-promoting and amidolytic activities in mixtures of Hageman factor (factor XII) and ellagic acid.
    Ratnoff OD; Saito H
    J Lab Clin Med; 1982 Aug; 100(2):248-60. PubMed ID: 7097109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The action of ellagic acid on the coagulation mechanism and experimental and clinical bleeding.
    Girolami A
    Haematol Lat; 1967; 10(3):291-301. PubMed ID: 5628788
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation of intrinsic blood coagulation by ellagic acid: insoluble ellagic acid-metal ion complexes are the activating species.
    Bock PE; Srinivasan KR; Shore JD
    Biochemistry; 1981 Dec; 20(25):7258-66. PubMed ID: 6797471
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the activation of Hageman factor (factor XII) by soluble human placental collagens types III, IV, and V.
    Koenig JM; Chahine A; Ratnoff OD
    J Lab Clin Med; 1991 Jun; 117(6):523-7. PubMed ID: 1646270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the activation of Hageman factor (factor XII) by aprotinin (Trasylol).
    Laurel MT; Ratnoff OD; Everson B
    J Lab Clin Med; 1992 May; 119(5):580-5. PubMed ID: 1374787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of gamma irradiation with 30 Gy on the coagulation system in leukoreduced fresh-frozen plasma.
    Weisbach V; Strobel J; Hahn B; Rödel F; Lotter M; Zingsem J; Ringwald J; Eckstein R
    Transfusion; 2007 Sep; 47(9):1658-65. PubMed ID: 17725731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.